Please login to the form below

Not currently logged in
Email:
Password:

Excellence in Healthcare Collaboration and Partnerships

Sponsored by

Finalist

Abbott's Small Steps to Change programme in collaboration with NHS rheumatologists to implement Treat to Target

Abbott Laboratories in association with DNA Medical Communications


Summary of work

The Treat to Target principles in rheumatoid arthritis include early referral, regular assessment and early diagnosis to make disease remission a realistic target for patients.

Evidence shows that earlier treatment improves patient outcomes. However, access to biologics, if appropriate, is often delayed as they are second‐line treatment and patients are often not reviewed regularly enough or treated to a target, which can make treatment decisions subjective. 

Abbott UK rolled‐out Treat to Target nationally to improve the management of patients, and improve the access to biologics for patients who require this treatment. Partnership with the most influential UK KOLs (including the 2011 European Rheumatology Professional Body (EULAR) chair) led to the inclusion of Treat to Target in the latest SIGN guidance and publication of a consensus on standardising assessment using DAS28 in a peer‐reviewed journal. 

Treat to Target was delivered through a revolutionary programme, Small Steps to Change (SSTC), allowing rheumatologists to break change into small steps, through low-/no-cost solutions delivering target‐driven regimens. SSTC changed routine practice in over 40 units with huge improvements in referral rates (10.76 to two weeks), assessment completion rates (16.7 per cent to 78.9‐100 per cent) and fewer patients with high disease activity at referral (40 per cent vs 25 per cent).

 

 

Executive summary as submitted


Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
GK Strategy

GK is award-winning independent communications agency specialising in delivering impactful strategies for clients across the healthcare market....

Latest intelligence

EU
Innovation in merger control and the impact on the pharmaceutical sector
Is focusing on pipeline products enough to assess regulatory risks?...
Nudge-nudge, think-think
Chris Ross examines the personal complexities of human behaviour – and explains why fun, emotion and peer endorsement could be key to designing effective behavioural change programmes...
Peoples Award
Quality in Care Diabetes 2018: the best in innovative diabetes care
Awards highlight new evidence-based approaches to improving care...

Infographics